Mobile Contingency Management for Smoking Cessation in Returning US Veterans
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
North Carolina
-
Durham, North Carolina, United States, 27706
- Duke University Medical Center
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Smoked at least 10 cigarettes on at least 15 of 30 days before screening
- Served during OEF/OIF/OND era
- Are willing to make a smoking cessation attempt
- Enrolled in the Durham VA for ongoing care
- English speaking
Exclusion Criteria:
- Use and unwillingness to stop use of other forms of nicotine such as cigars, pipes, or chewing tobacco
- Active diagnosis of a primary psychotic disorder per medical record
- Are currently imprisoned or in psychiatric hospitalization
- Severely impaired hearing or speech such that telephone counseling is not possible
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Mobile Contingency Management (mCM)
The mCM arm represents a proactive tele-health intervention that combines guideline based cognitive-behavioral smoking cessation telephone counseling, a tele-medicine clinic for access to nicotine replacement therapy (NRT), and intensive behavioral therapy administered via a smart phone (with carbon monoxide monitor) based application.
NRT may include nicotine patches (21 mg, 14 mg, and or 7 mg) used daily for six weeks from the smoking quit date.
Dosage will depend on participants' reported smoking patterns and carbon monoxide readings.
NRT may also include a "rescue" method, i.e., either nicotine gum or nicotine lozenge.
The participants' preferred NRT rescue method will be prescribed and used as needed to reduce smoking craving for six weeks from the smoking quit date.
|
Participants will be prescribed one form of nicotine replacement "rescue" treatment (i.e., gum, lozenge), and may choose nicotine gum as the preferred "rescue" treatment.
Participants will be instructed to use the rescue method as needed during the post-quit phase of the study to reduce cigarette cravings.
Other Names:
Participants will be asked to provide video recordings of themselves taking carbon monoxide readings in order to confirm smoking abstinence.
Participants are asked to upload these videos to the study's secured server, and are provided reinforcement for videos that suggest smoking abstinence.
Other Names:
Participants receive five sessions of cognitive-behavioral telephone counseling, and a participant manual.
The telephone counseling protocol included in this application is based on standard cognitive-behavioral therapy techniques shown to be efficacious for smoking cessation and is informed by behavioral treatment principles .
Other Names:
Participants will be prescribed nicotine patches to be used during the post-quit phase of the study.
Other Names:
Participants will be prescribed one form of nicotine replacement "rescue" treatment (i.e., gum, lozenge), and may choose nicotine lozenge as the preferred "rescue" treatment.
Participants will be instructed to use the rescue method as needed during the post-quit phase of the study to reduce cigarette cravings.
Participants in the experimental condition will be loaned a smart phone to use during the mobile contingency management intervention period.
The phone will be used to record videos of carbon monoxide readings to determine smoking abstinence.
Participants in the experimental condition will be loaned a CO monitor to use during the mobile contingency management intervention period.
The monitor will be used to determine carbon monoxide content in the breath as a measurement of smoking.
Other Names:
|
|
Active Comparator: Tele-Health for Smoking Ccessation
TELE-HEALTH FOR SMOKING CESSATION is a proactive tele-health intervention that will provide controls for therapist, medication, time and attention effects.
The tele-health intervention provides the same guideline based cognitive-behavioral smoking cessation telephone counseling, and tele-medicine clinic for access to NRT as in the mCM intervention.
NRT may include nicotine patches (21 mg, 14 mg, and or 7 mg) used daily for six weeks from the smoking quit date.
Dosage will depend on participants' reported smoking patterns and carbon monoxide readings.
NRT may also include a "rescue" method, i.e., either nicotine gum or nicotine lozenge.
The participants' preferred NRT rescue method will be prescribed and used as needed to reduce smoking craving for six weeks from the smoking quit date.
|
Participants will be prescribed one form of nicotine replacement "rescue" treatment (i.e., gum, lozenge), and may choose nicotine gum as the preferred "rescue" treatment.
Participants will be instructed to use the rescue method as needed during the post-quit phase of the study to reduce cigarette cravings.
Other Names:
Participants receive five sessions of cognitive-behavioral telephone counseling, and a participant manual.
The telephone counseling protocol included in this application is based on standard cognitive-behavioral therapy techniques shown to be efficacious for smoking cessation and is informed by behavioral treatment principles .
Other Names:
Participants will be prescribed nicotine patches to be used during the post-quit phase of the study.
Other Names:
Participants will be prescribed one form of nicotine replacement "rescue" treatment (i.e., gum, lozenge), and may choose nicotine lozenge as the preferred "rescue" treatment.
Participants will be instructed to use the rescue method as needed during the post-quit phase of the study to reduce cigarette cravings.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
smoking, self-report
Time Frame: 6 month follow-up (6 months post-quit attempt)
|
Participants' self-report of smoking in the past seven days will be measured at 6-month follow-up study visit.
|
6 month follow-up (6 months post-quit attempt)
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
saliva cotinine
Time Frame: 6 month follow-up (6 months post-quit attempt)
|
For participants reporting smoking abstinence at 6-months post treatment follow-up, the investigators will bio-verify smoking abstinence by collecting saliva samples that will be used to determine salivary cotinine levels.
|
6 month follow-up (6 months post-quit attempt)
|
|
smoking, self-report
Time Frame: Approx. ten weeks after enrollment (i.e., eight weeks after smoking quit attempt)
|
Participants' self-report of smoking in the past seven days will be measured at approximately eight weeks after the participant's initial smoking quit attempt.
|
Approx. ten weeks after enrollment (i.e., eight weeks after smoking quit attempt)
|
|
saliva cotinine
Time Frame: Approx. ten weeks after enrollment (i.e., eight weeks after smoking quit attempt)
|
For participants reporting smoking abstinence eight weeks after their smoking quit attempt, the investigators will bio-verify smoking abstinence by collecting saliva samples that will be used to determine salivary cotinine levels.
|
Approx. ten weeks after enrollment (i.e., eight weeks after smoking quit attempt)
|
|
smoking, self-report
Time Frame: 3 month follow-up (3 months post-quit attempt)
|
Participants' self-report of smoking in the past seven days will be measured at 3-month follow-up study visit.
|
3 month follow-up (3 months post-quit attempt)
|
|
saliva cotinine
Time Frame: 3 month follow-up (3 months post-quit attempt)
|
For participants reporting smoking abstinence at the 3-month follow-up contact, the investigators will bio-verify smoking abstinence by collecting saliva samples that will be used to determine salivary cotinine levels.
|
3 month follow-up (3 months post-quit attempt)
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Patrick S Calhoun, Ph.D., Duke University
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- Pro00050835
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.